About 3 results found for searched term "CBP-IN-1" (0.395 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21109 | Inobrodib | Epigenetic Reader Domain |
| CCS1477; CBP-IN-1; CBP/p300-IN-4 | ||
| Inobrodib (CCS1477, CBP-IN-1) is an orally active, potent and selective p300/CBP inhibitor. inobrodib binds to p300 and CBP with Kd values of 1.3 and 1.7 nM and has a 170/130 fold selectivity compared to BRD4 with a Kd of 222 nM. Inobrodib (CCS1477) acts by inhibiting the expression and function of androgen receptor (AR) and by inhibiting c-Myc. | ||
| M41660 | CBP-IN-1 | Epigenetic Reader Domain |
| CBP-IN-1 is a potent CBP inhibitor, with an IC50 of 1.5 nM. | ||
| M56043 | CBP/p300-IN-1 | Epigenetic Reader Domain |
| CBP/p300-IN-1 is a CBP/EP300 bromodomain inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
